Torrey Coast Foundation

ATLAS

The Torrey Coast Foundation is a dedicated philanthropic organisation committed to accelerating breakthroughs in the treatment of gastroesophageal cancers. Through its funding and strategic support of the Gastroesophageal Malignancies Investigator Network Initiative (GEMINI), the Foundation fosters a collaborative ecosystem that unites leading scientists, oncologists, and research institutions to drive translational discovery from bench to bedside.

GEMINI, funded by Torrey Coast, catalyses innovative preclinical research and expedites the development of novel therapies by enabling rapid access to patient-derived tumour samples, advanced cancer organoid models, and genetically engineered mouse models. This network accelerates the translation of promising laboratory findings into Phase I clinical trials, empowering investigators to pursue high-risk, high-reward projects that traditional funding avenues may overlook.

By connecting multidisciplinary teams and supporting bold approaches to drug discovery and combination strategies, the Torrey Coast Foundation aims to expand therapeutic options and improve outcomes for patients affected by these aggressive cancers. Through targeted grant making and partnership-driven research, the Foundation plays a pivotal role in pushing the frontiers of gastroesophageal cancer science toward meaningful clinical impact.